These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1526409)

  • 21. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 23. [Severe hepatitis caused by phenobarbital].
    Di Martino V; Mallat A; Duvoux C; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1994; 18(10):904-5. PubMed ID: 7875406
    [No Abstract]   [Full Text] [Related]  

  • 24. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cholestatic hepatitis caused by quinidine phenylethylbarbiturate, and sarcoidosis. Apropos of a case].
    Alix M; Mosquet B; Adrien A; Cuny G; Raffy P; Moulin M
    Therapie; 1989; 44(1):69. PubMed ID: 2734725
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].
    Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C
    Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of psychotropic drugs on thrombocytes aggregation in patients with epilepsy].
    Morozov GV; Semenova NV; Slastenko OA; Mishchenko AL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(11):60-1. PubMed ID: 15581040
    [No Abstract]   [Full Text] [Related]  

  • 29. [Exifone: 4 cases of hepatitis].
    Chichmanian RM; Mignot G; Brucker F; Greck T; Spreux A
    Gastroenterol Clin Biol; 1989 Apr; 13(4):428-9. PubMed ID: 2737398
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatitis caused by exifone].
    Grangé JD; Biour M; Merrouche Y; Roland J; Bodin F
    Gastroenterol Clin Biol; 1989 Apr; 13(4):427-8. PubMed ID: 2737397
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis caused by exifone].
    Pariente EA; Kapfer J
    Gastroenterol Clin Biol; 1989 Apr; 13(4):426. PubMed ID: 2737395
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxic hepatitis induced by psychotropic drugs and anticonvulsants].
    Araki S; Ikegawa S
    Nihon Rinsho; 1985 Jun; 43(6):1176-9. PubMed ID: 2864461
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fatal hepatitis probably caused by exifone (Adlone)].
    Pateron D; Bernuau J; Babany G; Larrey D; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1990; 14(3):294-5. PubMed ID: 2344918
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of hepatitis caused by exifone and bezafibrate].
    Gendreau-Tranquart C; Barbieux JP; Gillion JM; Furet Y; Picon L; Dorval ED; de Muret A; Metman EH
    Gastroenterol Clin Biol; 1989 Apr; 13(4):427. PubMed ID: 2737396
    [No Abstract]   [Full Text] [Related]  

  • 35. Two cases with epilepsy who manifested manic-depressive symptoms under barbiturates treatment.
    Kugoh T; Watanabe M; Obayashi K; Fujioka K; Hosokawa K
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):437-8. PubMed ID: 1762242
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 37. [Severe hypersensitivity to phenobarbital with erythema multiforme, cholestatic hepatitis and aplastic anemia].
    Palomeque A; Doménech P; Martínez-Gutiérrez A; Lequerica P
    An Esp Pediatr; 1986 May; 24(5):328-30. PubMed ID: 3740671
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of the psychosyndrome of alcoholic withdrawal using Atrium].
    Descloux A
    Rev Med Suisse Romande; 1971 Jan; 91(1):57-62. PubMed ID: 5164795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Severe medicamentous disease induced by aminazine and barbiturates].
    Sandler BB; Shersneva AD
    Sov Med; 1981; (9):116-7. PubMed ID: 6458895
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of barbiturates on the liver of rats exposed to carbon disulphide vapour.
    Freundt KJ; Liebaldt GP; Sieber KH
    Int Arch Arbeitsmed; 1974 Jan; 32(4):297-303. PubMed ID: 4821456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.